Actual Medicinal Product (AMP) -
Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc)
Name Details
Current Name
Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials
|
Start Date
15-09-2021
|
End Date
|
Previous Name
COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5ml dose dispersion for injection multidose vials
|
Start Date
18-03-2021
|
End Date
14-09-2021
|
|
Abbreviated Name
Spikevax COVID-19 mRNA Vaccine 0.5ml inj multidose vials
|
Start Date
30-11-2021
|
|
Summary
- Licensed Route
- Intramuscular
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
BNF |
Previous BNF
14040000
|
Start Date
12-01-2021
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
39326911000001101 |
12-01-2021 |
|
Actual Medicinal Product Pack (AMPP) Information